Paula Green - Jun 14, 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
SVP of Human Resources
Signature
/s/ William Solis, as Attorney-in-Fact for Paula Green
Stock symbol
TWST
Transactions as of
Jun 14, 2021
Transactions value $
-$1,430,868
Form type
4
Date filed
6/16/2021, 05:21 PM
Previous filing
May 24, 2021
Next filing
Jul 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Sale -$34K -300 -1.47% $113.48* 20.1K Jun 14, 2021 Direct F1
transaction TWST Common Stock Options Exercise $40.4K +6.8K +33.83% $5.95 26.9K Jun 14, 2021 Direct
transaction TWST Common Stock Options Exercise $20.7K +2.35K +8.75% $8.82 29.2K Jun 14, 2021 Direct
transaction TWST Common Stock Options Exercise $38.8K +1.66K +5.69% $23.33 30.9K Jun 14, 2021 Direct
transaction TWST Common Stock Options Exercise $81.3K +3.05K +9.86% $26.66 34K Jun 14, 2021 Direct
transaction TWST Common Stock Sale -$1.24M -10.9K -32.16% $113.34* 23K Jun 14, 2021 Direct F2
transaction TWST Common Stock Sale -$57.5K -500 -2.17% $114.96* 22.5K Jun 14, 2021 Direct F3
transaction TWST Common Stock Sale -$283K -2.44K -10.83% $115.90* 20.1K Jun 14, 2021 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -6.8K -38.1% $0.00 11K Jun 14, 2021 Common Stock 6.8K $5.95 Direct F5
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -2.35K -69.22% $0.00 1.05K Jun 14, 2021 Common Stock 2.35K $8.82 Direct F6
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -1.66K -5.98% $0.00 26.1K Jun 14, 2021 Common Stock 1.66K $23.33 Direct F7
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -3.05K -8.71% $0.00 32K Jun 14, 2021 Common Stock 3.05K $26.66 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sales price per share. The shares sold at prices ranging from $113.09 to $113.88 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F2 Represents the weighted average sales price per share. The shares sold at prices ranging from $113.00 to $113.81 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3 Represents the weighted average sales price per share. The shares sold at prices ranging from $114.53 to $115.08 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F4 Represents the weighted average sales price per share. The shares sold at prices ranging from $115.58 to $116.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F5 The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F6 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F7 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F8 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.